Clinical Trials Browser

Phase 3 × Suspended × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Clear all

NCT01755325 2018-04-25

Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+

Phase 3 Suspended

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive